Damien Garcon

Nantes, 44000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646].

Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646].

Journal: Metabolism: clinical and experimental

Published: September 19, 2024

PCSK9 inhibition protects mice from food allergy.

PCSK9 inhibition protects mice from food allergy.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: October 26, 2023

PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.

PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.

Journal: Metabolism: clinical and experimental

Published: April 21, 2023

Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9.

Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: December 20, 2022

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Identification of a Gain-of-Function LIPC Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Journal: Circulation

Published: July 28, 2022

PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol.

PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: July 08, 2022

Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond.

Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond.

Journal: Current atherosclerosis reports

Published: July 05, 2022

Corrigendum: PCSK9 is not secreted from mature differentiated intestinal cells.

Corrigendum: PCSK9 is not secreted from mature differentiated intestinal cells.

Journal: Journal of lipid research

Published: March 17, 2022

Transintestinal cholesterol excretion in health and disease.

Transintestinal cholesterol excretion in health and disease.

Journal: Current atherosclerosis reports

Published: October 26, 2021

PCSK9 is not secreted from mature differentiated intestinal cells.

PCSK9 is not secreted from mature differentiated intestinal cells.

Journal: Journal of lipid research

Published: December 04, 2020

Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice.

Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: July 17, 2020

A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Journal: Journal of lipid research

Published: April 14, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026